SeraCare Life Sciences, a developer and marketer of diagnostic products, and RayBiotech, a provider of proteomic tools, have announced that SeraCare will act as an agent for the sale of RayBiotech's full product line of antibody arrays, protein arrays, tissue microarrays and ELISA and EIA kits.
Subscribe to our email newsletter
The synergy of RayBiotech’s innovative portfolio with SeraCare’s global reach and expertise in virology, serology, immunology and molecular biology supports the acceleration of biomedical research and product development, the two companies said.
Susan Vogt, president and CEO of SeraCare Life Sciences, said: “The partnership with RayBiotech directly supports SeraCare’s growth strategy by expanding our offering of value-added proteomic tools to life sciences researchers around the world. RayBiotech is well regarded in the field of proteomics and their innovative products will benefit our client base while our mutual commitment to science and medicine offers opportunity for clinical advancements.”
Ray Huang, president of RayBiotech, said: “By adding SeraCare Life Sciences as an agent, we hope to achieve both increased demand for RayBiotech products in clinical and diagnostic markets and fuel increased opportunity for biomarker discovery and validation.”
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.